Images are for illustrative purposes only.
Eloralintide
Eloralintide (development code LY3841136) is a selective amylin receptor agonist, supplied here as unformulated lyophilized peptide for laboratory research. It is a 37-residue amylin analogue carrying a fatty-diacid chain that drives reversible albumin binding, the structural feature behind its extended research half-life.
What distinguishes eloralintide within the amylin class is receptor selectivity. In published human receptor assays it activates the AMY1 receptor considerably more potently than the calcitonin receptor or the AMY3 receptor, a narrower profile than broad amylin analogues such as cagrilintide. In vitro research focuses on amylin receptor binding and activation kinetics, receptor-subtype selectivity, and appetite and metabolic-homeostasis signaling, often benchmarked against the GLP-1 and GIP incretin pathways.
Eloralintide is investigational and has not been approved by any regulatory authority. Supplied as a lyophilized 10-vial kit at 10 mg per vial (100 mg total peptide), tested to ≥99% purity by HPLC with molecular identity confirmed by mass spectrometry. For in vitro research use only.